查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1886305

體外診斷試劑市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、技術、用途、最終用戶、地區和競爭格局分類，2020-2030年預測

In Vitro Diagnostic Reagents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Technology, By Use, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球體外診斷（IVD）試劑市場規模為787.5億美元，預計2030年將以5.35%的複合年成長率成長至1,076.6億美元。體外診斷（IVD）試劑是用於體外檢測的生化或生物物質，透過分析患者樣本，實現疾病的檢測、診斷、監測和治療。全球IVD試劑市場呈現強勁成長勢頭，主要得益於慢性病和傳染病在全球日益普遍，以及對個人化醫療需求的不斷成長，而這又需要高度特異性的診斷解決方案。對準確及時的診斷資訊的持續需求，是推動市場持續擴張的根本原因。

市場概覽
預測期 2026-2030
市場規模：2024年 787.5億美元
市場規模：2030年 1076.6億美元
複合年成長率：2025-2030年 5.35%
成長最快的細分市場 免疫測定
最大的市場 北美洲

主要市場促進因素

全球慢性病和傳染病的日益普及是體外診斷試劑發展的主要促進因素。癌症、糖尿病、心血管疾病和新出現的傳染病病原體等疾病需要持續、廣泛的診斷檢測，以進行篩檢、準確診斷和疾病管理。

主要市場挑戰

繁瑣的監管要求嚴重阻礙了全球體外診斷（IVD）試劑市場的成長。複雜的認證流程和漫長的核准時間限制了新診斷產品的及時上市和供應。

主要市場趨勢

向分散式和即時檢測（POC​​）的轉變正在拓展診斷能力，使其超越傳統實驗室環境，讓檢測更貼近患者，並有助於更及時地做出臨床決策。這一趨勢要求開發穩定可靠、易於使用且與小型攜帶式設備相容的試劑配方。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球體外診斷（IVD）試劑市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型（抗體、純化蛋白質和胜肽、寡核苷酸、其他）
    • 依技術分類（免疫測定、臨床化學、分子診斷、微生物學、血液學、其他）
    • 依用途分類（臨床用途、研究用途、其他）
    • 按最終用戶分類（體外診斷試劑生產商、學術機構和研究實驗室、醫院實驗室、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美體外診斷（IVD）試劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲體外診斷（IVD）試劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區體外診斷試劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲體外診斷（IVD）試劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲體外診斷（IVD）試劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球體外診斷（IVD）試劑市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Thermo Fisher Scientific Inc
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc
  • Agilent Technologies, Inc.
  • QIAGEN NV
  • Merck KGaA
  • Beckman Coulter, Inc
  • Hologic, Inc
  • Abcam Ltd
  • Bio-Techne Corp

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 22716

The Global In Vitro Diagnostic (IVD) Reagents Market, valued at USD 78.75 Billion in 2024, is projected to experience a CAGR of 5.35% to reach USD 107.66 Billion by 2030. In vitro diagnostic (IVD) reagents are biochemical or biological substances essential for tests conducted outside the human body, enabling the detection, diagnosis, monitoring, and treatment of diseases by analyzing patient samples. The global IVD reagents market demonstrates robust growth, primarily supported by the increasing worldwide prevalence of chronic and infectious diseases, coupled with a rising demand for personalized medicine which necessitates highly specific diagnostic solutions. This consistent requirement for accurate and timely diagnostic information underpins the sustained expansion of the market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 78.75 Billion
Market Size 2030USD 107.66 Billion
CAGR 2025-20305.35%
Fastest Growing SegmentImmunoassay
Largest MarketNorth America

Key Market Drivers

The escalating global prevalence of chronic and infectious diseases is a primary driver for in vitro diagnostic reagents. Conditions such as cancer, diabetes, cardiovascular diseases, and emerging infectious pathogens necessitate continuous and extensive diagnostic testing for screening, accurate diagnosis, and disease management. This persistent need directly increases the consumption of IVD reagents across diverse diagnostic platforms. For example, the substantial global cancer burden underscores this demand.

Key Market Challenges

The extensive regulatory requirements significantly impede the growth of the Global In Vitro Diagnostic (IVD) Reagents Market. The complex certification processes and lengthy timelines restrict the timely introduction and availability of new diagnostic products. For example, according to a MedTech Europe survey in 2024, the choice of the EU as the first launch geography for IVD large manufacturers dropped by 40% due to regulatory burdens, indicating a diversion of innovation away from this critical market. This directly translates to fewer innovative reagents reaching patients and healthcare providers, thus limiting market expansion.

Key Market Trends

The shift towards decentralized and point-of-care (POC) testing is expanding diagnostic capabilities beyond traditional laboratory settings, bringing testing closer to patients and facilitating more immediate clinical decisions. This trend necessitates the development of robust, user-friendly reagent formulations compatible with smaller, often portable devices. Such decentralization is crucial for improving access to timely diagnostics, particularly in remote areas or emergency situations.

Key Market Players

  • Thermo Fisher Scientific Inc
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc
  • Agilent Technologies, Inc.
  • QIAGEN N.V.
  • Merck KGaA
  • Beckman Coulter, Inc
  • Hologic, Inc
  • Abcam Ltd
  • Bio-Techne Corp

Report Scope:

In this report, the Global In Vitro Diagnostic (IVD) Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

In Vitro Diagnostic (IVD) Reagents Market, By Type:

  • Antibodies
  • Purified Proteins and Peptides
  • Oligonucleotides
  • Others

In Vitro Diagnostic (IVD) Reagents Market, By Technology:

  • Immunoassay
  • Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Hematology
  • Others

In Vitro Diagnostic (IVD) Reagents Market, By Use:

  • Clinical Use
  • Research Use
  • Others

In Vitro Diagnostic (IVD) Reagents Market, By End User:

  • IVD Manufacturers
  • Academic Institutes & Research Laboratories
  • Hospital Laboratories
  • Others

In Vitro Diagnostic (IVD) Reagents Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global In Vitro Diagnostic (IVD) Reagents Market.

Available Customizations:

Global In Vitro Diagnostic (IVD) Reagents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global In Vitro Diagnostic (IVD) Reagents Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Antibodies, Purified Proteins and Peptides, Oligonucleotides, Others)
    • 5.2.2. By Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Others)
    • 5.2.3. By Use (Clinical Use, Research Use, Others)
    • 5.2.4. By End User (IVD Manufacturers, Academic Institutes & Research Laboratories, Hospital Laboratories, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America In Vitro Diagnostic (IVD) Reagents Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Technology
    • 6.2.3. By Use
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Use
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Use
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Use
        • 6.3.3.2.4. By End User

7. Europe In Vitro Diagnostic (IVD) Reagents Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Technology
    • 7.2.3. By Use
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Use
        • 7.3.1.2.4. By End User
    • 7.3.2. France In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Use
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Use
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Use
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Use
        • 7.3.5.2.4. By End User

8. Asia Pacific In Vitro Diagnostic (IVD) Reagents Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Technology
    • 8.2.3. By Use
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Use
        • 8.3.1.2.4. By End User
    • 8.3.2. India In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Use
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Use
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Use
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Use
        • 8.3.5.2.4. By End User

9. Middle East & Africa In Vitro Diagnostic (IVD) Reagents Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Technology
    • 9.2.3. By Use
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Use
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Use
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Use
        • 9.3.3.2.4. By End User

10. South America In Vitro Diagnostic (IVD) Reagents Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Technology
    • 10.2.3. By Use
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Use
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Use
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina In Vitro Diagnostic (IVD) Reagents Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Use
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global In Vitro Diagnostic (IVD) Reagents Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Becton, Dickinson and Company
  • 15.3. Bio-Rad Laboratories, Inc
  • 15.4. Agilent Technologies, Inc.
  • 15.5. QIAGEN N.V.
  • 15.6. Merck KGaA
  • 15.7. Beckman Coulter, Inc
  • 15.8. Hologic, Inc
  • 15.9. Abcam Ltd
  • 15.10. Bio-Techne Corp

16. Strategic Recommendations

17. About Us & Disclaimer